Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

NCT04520074 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

590

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin

Sponsor

Fudan University